Skip to main content

Featured

Geopolitical Tensions Rattle Wall Street as Futures Slide on Trump’s Iran Warning

  Markets tumbled Thursday morning as renewed geopolitical uncertainty sent U.S. stock futures sharply lower, with investors reacting to President Trump’s latest remarks that the war with Iran is “not yet over.”   U.S. stock futures stumbled early Thursday after President Trump’s national address failed to signal a clear end to the ongoing U.S.–Israeli conflict with Iran. Futures tied to the Dow Jones Industrial Average dropped more than 600 points , while S&P 500 futures fell 1.5% and Nasdaq 100 futures slid 2% , reflecting heightened investor anxiety.  The market’s reaction was driven largely by Trump’s assertion that the conflict is not yet resolved, despite reports that Iran’s president has approached the U.S. about a potential ceasefire. Trump emphasized that any agreement would depend on reopening the Strait of Hormuz , a critical global energy chokepoint. He also warned that U.S. forces would “hit Iran hard” before any withdrawal in the coming weeks.  ...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment